Supply and delivery of small volume parenterals and insulin devices to the department of health (2027-2030)

• Closing Date and Time: 20 July 2026 at 11:00 am.
• Non-compulsory Online Briefing Session: 5 June 2026 at 10:00 via MS Teams. Join using the link: https://teams.microsoft.com/meet/311929459314797?p=4cK2vUeKrJLWHOx77f.

• All enquiries and information requests: Email [email protected].
• Enquiry hours: 07:30 - 15:30.
• Physical submission address: DR AB Xuma Building, 1112 Voortrekker Road, Pretoria Townlands 351-JR, PRETORIA, 0143.

• Obtain bid documents from the Department of Health website (www.health.gov.za) or the National Treasury e-tender portal. Navigate via the 'TENDERS' tab, then the 'PHARMACEUTICAL TENDERS' tab to download. Documents published on 22 May 2026.
• Submit completed bids physically to: DR AB Xuma Building, 1112 Voortrekker Road, Pretoria Townlands 351-JR, PRETORIA, 0143.
• Closing date and time: 20 July 2026 at 11:00 am. Late submissions will be disqualified.
• Submit all enquiries timeously to [email protected] to allow for responses before the tender closes. Include any registration or document access issues.
• Returnable documents (e.g., signed forms, declarations) are required as per the full bid document.

Evaluation occurs in four phases:

• Phase I: Compliance with mandatory administrative requirements (e.g., submission completeness, valid registrations).
• Phase II: Compliance with product, technical, and legal mandatory requirements (e.g., specifications, standards, legal capacity).
• Phase III: Compliance with B-BBEE requirements as per Section 9 of the Special Requirements and Conditions of Contract (SRCC).
• Phase IV: Recommendation and award based on compliance with all prior phases.
• Bidders must be registered on the National Treasury e-tender portal.
• Open to all bidders meeting the above criteria. No scoring weights or thresholds are specified in the provided text.

• Scope: Supply and delivery of small volume parenterals and insulin devices to the Department of Health.
• Contract Period: 01 May 2027 to 30 April 2030 (36 months).
• Bidders must demonstrate capacity to meet volume, quality, and delivery timelines for the specified medical supplies.

• Mandatory compliance with B-BBEE requirements as per Section 9 of the Special Requirements and Conditions of Contract (SRCC). This is evaluated in Phase III.
• Compliance with all mandatory administrative, product, technical, and legal requirements as outlined in the bid document.
• Bidders must be registered on the National Treasury e-tender portal.

Closing Date: 20 July 2026 at 11:00. Contract Period: 01 May 2027 to 30 April 2030.

Returnable Documents: Invoices must include all fields per Annexure B (Invoice Minimum Data Requirements). Mandatory sections: (1) Invoice header: 'TAX INVOICE', 'COPY TAX INVOICE (Supplier)', or 'COPY TAX INVOICE (Facility)'. (2) Supplier information: logo, name, NDoH Supplier Code, CSD registration (MAAA), company registration, VAT number, distributor name. (3) Supplier contact details: physical/postal addresses, query contact number/email, debtors contact number/email. (4) 'Deliver To' information: account number, facility name, demander code, MHFL code, delivery address, receiver name/rank/phone. (5) Invoice details: unique invoice number, invoice date, page count, invoice number barcode (1D). (6) Order details: PO number, PO barcode (1D), order captured date, special instructions. (7) Line-item details: EAN-13 barcode, generic/brand product description, contract/addendum/item number (format: Contract#_Addendum#_Item#), quantities ordered/supplied, batch number (separate line per batch), expiry date (separate line per expiry), unit price (VAT inclusive, 4 decimal places), line total. (8) Summary totals: Total Ex VAT (2 decimal places), VAT amount (2 decimal places), Total Sum (Ex VAT + VAT, 2 decimal places). (9) 'Invoice To' information: pay office name/address, VAT number, phone. (10) Proof of Delivery: date received, receiver's printed name, PERSAL number, signature, carton count, facility stamp, GRV number, claim reference number.

General: Must be a registered supplier with valid NDoH Supplier Code and CSD registration (MAAA). Must have valid Company Registration and VAT number. Authorized distributor details must be provided if applicable. Must comply with South African public sector procurement regulations. Technical: Must generate 1D barcodes for invoices and POs (symbology specified). Must demonstrate capacity to supply small volume parenterals and insulin devices as per contract specifications. Must adhere to invoicing data dictionary (all mandatory fields). Must track batch and expiry dates for all delivered items.

Scope: Supply and delivery of small volume parenterals and insulin devices for the period 01 May 2027 to 30 April 2030. Deliverables must adhere to Contract Circular and Purchase Order specifications. Key requirements: Brand names and generic product descriptions must match Contract Circular and Purchase Order. Each invoice line must include: contract number, addendum number (2 digits), item number (3 digits), quantity ordered/supplied, batch number (separate line per batch), expiry date (separate line per expiry), unit price (VAT inclusive, 4 decimal places), and line total. Item numbers must correspond with Generic Product Description. Proof of Delivery (POD) must include: date received, receiver's printed name, PERSAL number, signature, number of cartons, facility stamp, and GRV number.

Pricing: Unit prices must include VAT and delivery, formatted to 4 decimal places. Invoice totals must include: Total Ex VAT (2 decimal places), VAT amount (2 decimal places), Total Sum (Ex VAT + VAT, 2 decimal places). Each line total is unit price multiplied by delivered quantity. Invoices must reference a single Purchase Order number per invoice. Barcodes (1D) required for invoice numbers and Purchase Order numbers. Supplier logo, name, NDoH Supplier Code, CSD registration, company registration, and VAT number must be clearly stated.

CSD Registration: Suppliers must provide a valid CSD registration number (MAAA format) as per the contract. Supplier details (name, NDoH Supplier Code, company registration, VAT number) must match contract records. Distributor information must be explicitly stated where applicable. Invoices must use 'TAX INVOICE' or 'COPY TAX INVOICE' headers as appropriate. All mandatory fields in Annexure B must be completed.

Closing date: 20 July 2026 at 11:00. Non-compulsory online briefing session: 5 June 2026 at 10:00 via MS Teams.

Queries: [email protected]. Submission address: Directorate: Affordable Medicines, Dr AB Xuma Building, 1112 Voortrekker Road, Pretoria Townlands 351-JR, Pretoria, 0187. Pharmaceutical Tender Box (Reception Area). DTI NIP Programme contact: Ms R Muthan, Tel: (012) 394 1288, Mobile: (066) 301 2051, Email: [email protected].

Submit bids by 20 July 2026 at 11:00 to the Pharmaceutical Tender Box at Dr AB Xuma Building, 1112 Voortrekker Road, Pretoria Townlands 351-JR, Pretoria. Late bids will not be accepted. Use only official bid forms (do not re-type). Bid validity period: 180 days. Non-compulsory online briefing: MS Teams, 5 June 2026 at 10:00. Required documents: Bid Document Checklist (Paragraph 3), Bid Documents (Paragraph 4.1.1–4.1.7), Consortium/JV declarations (Paragraph 4.3), Submission of bids (Paragraph 9), Completion of documents and bid submission (Paragraph 10). Failure to submit required forms or comply with conditions may disqualify the bid.

Evaluation uses the 90/10 preference point system: 90 points for price (lowest acceptable tender scores highest), 10 points for B-BBEE Status Level of Contributor (Level 1: 10 points, Level 2: 9 points, Level 3: 8 points, Level 4: 6 points, Level 5: 5 points, Level 6: 4 points, Level 7: 3 points, Level 8: 2 points, Non-compliant: 0 points). Disqualification risks: state employees or directors, tender defaulters, restricted suppliers, financial insolvency, or failure to meet tax/B-BBEE/GMP compliance. Technical evaluation includes compliance with GMP, product specifications, and supply capacity. Legal evaluation includes submission of all declarations (e.g., conflicts of interest, third-party sourcing) and agreement to GCC/SRCC.

Supply and delivery of small volume parenterals and insulin devices for the period 01 May 2027 to 30 April 2030. Products must comply with Good Manufacturing Practice (GMP) and Medicines and Related Substances Act. Third-party sourcing requires unconditional written undertakings from suppliers (use PBD1.2 template). National Industrial Participation (NIP) Programme applies if imported content exceeds US$10 million (or equivalent). NIP obligation: 30% of imported content for contracts meeting thresholds. Successful bidders must report contracts >R10 million to DTI within 5 working days of award.

Submit pricing on official forms. Performance guarantees required for NIP compliance (if applicable). Successful bidders must provide performance guarantees to DTI, submit business concepts for approval, and implement approved plans with bi-annual progress reports. Financial solvency declaration (PBD11) required. No explicit payment terms or bid bond requirements stated beyond NIP obligations.

Tax Compliance: Submit SARS Tax Compliance Status (TCS) PIN or CSD registration number. Apply for TCS PIN via SARS e-filing (www.sars.gov.za). If no TCS PIN, provide CSD number. Each party in consortia/JVs must submit separate TCS/CSD documentation. VAT registration number required. B-BBEE: Submit valid SANAS-accredited B-BBEE certificate or sworn affidavit (EME/QSE) to claim preference points. Disclosure of conflicts of interest (SBD4) and financial solvency (PBD11) required. Foreign suppliers must complete additional questionnaires. Restricted suppliers or tender defaulters are disqualified. Must declare compliance with GMP (PBD5) and Medicines and Related Substances Act.